References
- Shah K J, Robins D G, White RHR. Renal scarring and vesi-coureteral reflux. Arch Dis Child 1978; 53: 210–217
- White RHR. Vesicoureteric reflux and renal scarring. Arch Dis Child 1989; 64: 407–412
- Slotki I N, Asscher A W. Prevention of scarring in experimental pyelonephritis in the rat by early antibiotic therapy. Nephron 1982; 30: 262–268
- Glauser M P, Lyons J M, Braude Al. Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. J Clin Invest 1978; 61: 403–407
- Matsumoto T, Mizunoe Y, Sakamoto N, Tanaka M, Kumazawa J. Increased renal scarring by bacteria with mannose-sensitive pili. Urol Res 1990; 18: 299–303
- Matsumoto T, Mizunoe Y, Sakamoto N, Kumazwa J. Suitability of colchicine and superoxide dismutase for the suppression of renal scarring following an infection with bacteria showing mannose-sensitive pili. Nephron 1990; 56: 130–135
- Fauci A S, Dale D C, Balow J E. Glucocorticoid therapy: Mechanisms of action and clinical considerations. Ann Intern Med 1976; 84: 304–315
- Matsumoto T, Mizunoe Y, Ogata N, Tanaka M, Kumazawa J. Role of superoxide in renal scarring following infection by MS-piliated bacteria. Urol Res 1991; 19: 229–233
- Meylan P R, Glauser M P. Failure of dexamethasone to prevent polymorphonuclear leukocyte infiltration during experimental acute exudative pyelonephritis and to reduce subsequent chronic scarring. J Infect Dis 1988; 157: 480–485